Safety and efficacy of consolidative stereotactic radiotherapy for oligo-residual EGFR-mutant non-small cell lung cancer after first-line third-generation EGFR-tyrosine kinase inhibitors: a single-arm, phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of consolidative stereotactic radiotherapy for oligo-residual EGFR-mutant non-small cell lung cancer after first-line third-generation EGFR-tyrosine kinase inhibitors: a single-arm, phase 2 trial

DOI Full Paper Access

22

Citations

24

References

2024

Year

Yue Zhou, Peng Lin, Fei Liang, Li Chu, Xiao Chu, Xi Yang, Junhua Zhang, Tiantian Guo, Shanshan Jiang, Yechun Pang,

EClinicalMedicine

Abstract

Hui Lan Public Welfare and the Chinese Society of Clinical Oncology Foundation.

References

	Year	Citations

Page 1